What is Bruker's investments - amortized cost basis?

Bruker (BRKR) reported investments - amortized cost basis of $25.9M in Q1 2026.

How has Bruker's investments - amortized cost basis changed year-over-year?

Bruker's investments - amortized cost basis decreased by 24.3% year-over-year, from $34.2M to $25.9M.

Bruker BRKR Investments - Amortized Cost Basis

Investments - Amortized Cost Basis at other companies

Agilent TechnologiesA

——

IlluminaILMN

——

Bio-Rad LaboratoriesBIO

——

Other financials

Income statement

See full

Revenue$823.4M+2.7%

Gross profit$379.8M-2.9%

Operating income$10.2M-67.9%

Net income$14.4M-17.2%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$137.6M-26.7%

Total debt$1.7B-20.9%

Total equity$2.5B+34.6%

Total assets$6.1B+3.3%

Cash flow

See full

Operating cash flow$71.2M+9.5%

CapEx$24.2M-6.9%

Free cash flow$47.0M+20.5%

Valuation

See full

Market cap$8.71B-13.2%

Enterprise value$10.25B-14.9%

P/S2.5×-0.4×

Profitability

See full

Gross margin45.3%-3.7pp

Operating margin1.3%-5.0pp

Net margin-0.6%-10.0pp

FCF margin1.5%-3.6pp

Returns & leverage

See full

Return on equity-1%-21.2pp

Debt / equity0.7×-0.5×

Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's investments - amortized cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bruker's investments - amortized cost basis?: Bruker (BRKR) reported investments - amortized cost basis of $25.9M in Q1 2026.
How has Bruker's investments - amortized cost basis changed year-over-year?: Bruker's investments - amortized cost basis decreased by 24.3% year-over-year, from $34.2M to $25.9M.